Teva Pharmaceutical Industries Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TEVJF research report →
About the company
Teva Pharmaceutical Industries Limited operates as a global pharmaceutical enterprise, engaging in the research, production, marketing, and distribution of generic medications, specialized pharmaceutical products, and biopharmaceuticals. The company's reach extends across North America, Europe, and various other international markets. Its extensive product offerings include sterile formulations, hormonal therapies, highly potent drugs, and cytotoxic compounds, available in a wide array of dosage forms.
- CEO
- Richard D. Francis
- IPO
- 2010
- Employees
- 37,000
- HQ
- Tel Aviv, IL
Price Chart
- Market Cap
- $38.43B
- P/E
- 25.38
- P/S
- 2.34
- P/B
- 4.87
- EV/EBITDA
- 16.24
- Div Yield
- 0.00%
- Gross Margin
- 52.06%
- Op Margin
- 18.83%
- Net Margin
- 9.03%
- ROE
- 20.79%
- ROIC
- 11.17%
- Revenue
- $18.68B · 12.92%
- Net Income
- $1.53B · 193.19%
- EPS
- $1.33 · 191.72%
- Op Income
- $2.16B
- FCF YoY
- 241.36%
- 52W High
- $37.00
- 52W Low
- $14.00
- 50D MA
- $29.93
- 200D MA
- $26.76
- Beta
- 0.85
- Avg Volume
- 11
Get TickerSpark's AI analysis on TEVJF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 20, 23 | Fox Christine | other | 253,968 |
| Nov 20, 23 | Fox Christine | other | 0 |
| Nov 15, 23 | Conway Vikki L | other | 33,482 |
| Nov 15, 23 | Bergwerk Dov | other | 33,482 |
| Oct 13, 23 | Bergwerk Dov | other | 0 |
| Oct 13, 23 | Bergwerk Dov | other | 17,505 |
| Oct 13, 23 | Bergwerk Dov | other | 7,010 |
| Oct 13, 23 | Bergwerk Dov | other | 31,075 |
| Oct 13, 23 | Bergwerk Dov | other | 27,501 |
| Oct 13, 23 | Bergwerk Dov | other | 12,754 |
Our TEVJF coverage
Recent articles, reports, and earnings notes.
No research on TEVJF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TEVJF report →Similar companies
Peers in the same neighborhood.